 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
  |
 |
|||||||
|
|||
|
(PPH)
|
|
|
|
November 09, 2009 |
|
|
|
|
|
Schering-Plough Corp. (SGP) is scheduled to be acquired by Merck & Co. Inc. (MRK) effective 11/4/2009. Upon completion, SGP will be deleted from the index. Merck & Co. Inc. (MRK) shares will be increased to 30.0738 in order to account for the MRK shares received for the index's holding of SGP (0.5767 shares of MRK for each share of SGP). Finally, $147.00 in cash will be added to the index [in order to account for the cash consideration received for the index's holding of SGP - $10.50/SGP share] until distributed by the Bank of NY Mellon on ex-date 11/9/2009.
|
||
|
November 04, 2009 |
Merck & Co. Inc. |
MRK |
30.0738 |
|
|
Schering-Plough Corp. (SGP) is scheduled to be acquired by Merck & Co. Inc. (MRK) effective 11/4/2009. Upon completion, SGP will be deleted from the index. Merck & Co. Inc. (MRK) shares will be increased to 30.0738 in order to account for the MRK shares received for the index's holding of SGP (0.5767 shares of MRK for each share of SGP). Finally, $147.00 in cash will be added to the index [in order to account for the cash consideration received for the index's holding of SGP - $10.50/SGP share] until distributed by the Bank of NY Mellon on an ex-date TBA. (Please note MRK CUSIP Change)
|
||
|
November 04, 2009 |
Schering-Plough Corp. |
SGP |
|
|
|
Schering-Plough Corp. (SGP) is scheduled to be acquired by Merck & Co. Inc. (MRK) effective 11/4/2009. Upon completion, SGP will be deleted from the index. Merck & Co. Inc. (MRK) shares will be increased to 30.0738 in order to account for the MRK shares received for the index's holding of SGP (0.5767 shares of MRK for each share of SGP). Finally, $147.00 in cash will be added to the index [in order to account for the cash consideration received for the index's holding of SGP - $10.50/SGP share] until distributed by the Bank of NY Mellon on an ex-date TBA.
|
||
|
October 21, 2009 |
|
|
|
|
|
Wyeth (WYE) is scheduled to be acquired by Pfizer Inc. (PFE) effective 10/16/2009. For each share of WYE, holders will receive $33.00 and 0.985 shares of PFE. WYE will be deleted from the index effective 10/16/2009. In addition, the shares for PFE will be increased to 69.82. Finally, a cash component of $396.00 will be held in the index until distributed by the Bank of NY Mellon on ex-date 10/21/2009.
|
||
|
October 16, 2009 |
Pfizer Inc. |
PFE |
69.82 |
|
|
Wyeth (WYE) is scheduled to be acquired by Pfizer Inc. (PFE) effective 10/16/2009. For each share of WYE, holders will receive $33.00 and 0.985 shares of PFE. WYE will be deleted from the index effective 10/16/2009. In addition, the shares for PFE will be increased to 69.82. Finally, a cash component of $396.00 will be held in the index until distributed by the Bank of NY Mellon on an ex-date TBA.
|
||
|
October 16, 2009 |
Wyeth |
WYE |
|
|
|
Wyeth (WYE) is scheduled to be acquired by Pfizer Inc. (PFE) effective 10/16/2009. For each share of WYE, holders will receive $33.00 and 0.985 shares of PFE. WYE will be deleted from the index effective 10/16/2009. In addition, the shares for PFE will be increased to 69.82. Finally, a cash component of $396.00 will be held in the index until distributed by the Bank of NY Mellon on an ex-date TBA.
|
||
|
March 04, 2009 |
|
|
|
|
|
Advanced Medical Optics Inc. (EYE) is scheduled to be acquired by Abbott Laboratories (ABT) effective 2/27/2009. Upon completion, EYE will be deleted from the index. $4.8888 in cash will be added to the index until distributed by the Bank of NY Mellon on ex-date 3/4/2009.
|
||
|
February 27, 2009 |
Advanced Medical Optics Inc. |
EYE |
|
|
|
Advanced Medical Optics Inc. (EYE) is scheduled to be acquired by Abbott Laboratories (ABT) effective 2/27/2009. Upon completion, EYE will be deleted from the index. $4.88884 in cash will be added to the index until distributed by the Bank of NY Mellon on an ex-date TBA.
|
||
|
December 29, 2008 |
Mylan Inc. |
MYL |
|
|
|
Change in primary listing to NASDAQ only
|
||
|
February 01, 2006 |
Ivax Corp. |
IVX |
|
|
|
The Pharmaceutical HOLDR Index(IPH) will trade Ex the IVAX Corp. (IVX) merger consideration of $60.94 on 2/1/2006. Ivax Corp. (IVX) is scheduled to be acquired by Teva Pharmaceutical Ind. Ltd. (TEVA) effective 1/26/2006. IVX shareholders will receive $26.00 or 0.8471 shares of TEVA ADS. Upon completion, IVX will be deleted from the index There is 2.34375 shares of IVX in the index. $60.94 of cash will be included in the index to account for the merger consideration until 2/1/2006, the EX distribution date .
|
||
|
February 01, 2006 |
Ivax Corp. |
IVX |
|
|
|
The Pharmaceutical HOLDR Index(IPH) will trade Ex the IVAX Corp. (IVX) merger consideration of $60.94 on 2/1/2006. Ivax Corp. (IVX) is scheduled to be acquired by Teva Pharmaceutical Ind. Ltd. (TEVA) effective 1/26/2006. IVX shareholders will receive $26.00 or 0.8471 shares of TEVA ADS. Upon completion, IVX will be deleted from the index There is 2.34375 shares of IVX in the index. $60.94 of cash will be included in the index to account for the merger consideration until 2/1/2006, the EX distribution date .
|
||
|
February 01, 2006 |
Ivax Corp. |
IVX |
|
|
|
The Pharmaceutical HOLDR Index(IPH) will trade Ex the IVAX Corp. (IVX) merger consideration of $60.94 on 2/1/2006. Ivax Corp. (IVX) is scheduled to be acquired by Teva Pharmaceutical Ind. Ltd. (TEVA) effective 1/26/2006. IVX shareholders will receive $26.00 or 0.8471 shares of TEVA ADS. Upon completion, IVX will be deleted from the index There is 2.34375 shares of IVX in the index. $60.94 of cash will be included in the index to account for the merger consideration until 2/1/2006, the EX distribution date .
|
||
|
January 26, 2006 |
Ivax Corp. |
IVX |
|
|
|
Ivax Corp. (IVX) is scheduled to be acquired by Teva Pharmaceutical Ind. Ltd. (TEVA) effective 1/26/2006. IVX shareholders will receive $26.00 or 0.8471 shares of TEVA ADS. Upon completion, IVX will be deleted from the index There is 2.34375 shares of IVX in the index. $60.94 of cash will be included in the index to account for the merger consideration until an EX distribution date is determined for the HOLDRS.
|
||
|
January 26, 2006 |
Ivax Corp. |
IVX |
|
|
|
Ivax Corp. (IVX) is scheduled to be acquired by Teva Pharmaceutical Ind. Ltd. (TEVA) effective 1/26/2006. IVX shareholders will receive $26.00 or 0.8471 shares of TEVA ADS. Upon completion, IVX will be deleted from the index.
|
||
|
January 26, 2006 |
Ivax Corp. |
IVX |
|
|
|
Ivax Corp. (IVX) is scheduled to be acquired by Teva Pharmaceutical Ind. Ltd. (TEVA) effective 1/26/2006. IVX shareholders will receive $26.00 or 0.8471 shares of TEVA ADS. Upon completion, IVX will be deleted from the index There is 2.34375 shares of IVX in the index. $60.94 of cash will be included in the index to account for the merger consideration until an EX distribution date is determined for the HOLDRS.
|
||
|
January 26, 2006 |
Ivax Corp. |
IVX |
|
|
|
Ivax Corp. (IVX) is scheduled to be acquired by Teva Pharmaceutical Ind. Ltd. (TEVA) effective 1/26/2006. IVX shareholders will receive $26.00 or 0.8471 shares of TEVA ADS. Upon completion, IVX will be deleted from the index.
|
||
|
January 26, 2006 |
Ivax Corp. |
IVX |
|
|
|
Ivax Corp. (IVX) is scheduled to be acquired by Teva Pharmaceutical Ind. Ltd. (TEVA) effective 1/26/2006. IVX shareholders will receive $26.00 or 0.8471 shares of TEVA ADS. Upon completion, IVX will be deleted from the index There is 2.34375 shares of IVX in the index. $60.94 of cash will be included in the index to account for the merger consideration until an EX distribution date is determined for the HOLDRS.
|
||
|
January 26, 2006 |
Ivax Corp. |
IVX |
|
|
|
Ivax Corp. (IVX) is scheduled to be acquired by Teva Pharmaceutical Ind. Ltd. (TEVA) effective 1/26/2006. IVX shareholders will receive $26.00 or 0.8471 shares of TEVA ADS. Upon completion, IVX will be deleted from the index.
|
||
|
June 08, 2005 |
Advanced Medical Optics Inc. |
AVO |
|
|
|
|
||
|
June 08, 2005 |
Advanced Medical Optics Inc. |
AVO |
|
|
|
|
||
|
July 01, 2002 |
Allergan Inc. |
AGN |
|
|
|
Allergan Inc. (AGN) is anticipated to complete the spin-off of Advanced Medical Optics. (AVO). AGN shareholder will receive approximately 0.22222 of a share of AVO for share share of AGN held. The price of AGN will be adjusted to reflect this spin off.
|
||
|
July 01, 2002 |
Advanced Medical Optics |
AVO |
|
|
|
Allergan Inc. (AGN) is anticipated to complete the spin-off of Advanced Medical Optics. (AVO). AGN shareholder will receive approximately 0.22222 of a share of AVO for share share of AGN held.
|
||
|
March 11, 2002 |
American Home Products Corp. |
AHP |
|
|
|
New CUSIP: 983024100.
|
||
|
August 07, 2001 |
Zimmer Holdings Inc. |
ZMH |
|
|
|
Bristol-Myers Squibb Co. (BMY) is expected to distribute Zimmer Holdings Inc. (ZMH) to BMY shareholders. BMY shareholders will receive one share of ZMH for every 10 shares held.
|
||
|
August 07, 2001 |
Bristol-Myers Squibb Co. |
BMY |
|
|
|
Bristol-Myers Squibb Co. (BMY) is expected to distribute Zimmer Holdings Inc. (ZMH) to BMY shareholders. BMY shareholders will receive one share of ZMH for every 10 shares held. BMY's price will be adjusted to reflect this spin off.
|
||
|
September 26, 2000 |
Andrx Corp.-Andrx Group |
ADRXD |
|
|
|
|
||
|
September 21, 2000 |
Andrx Corporation |
ADRX |
0.2978 |
|
|
As a result of the reorganization, each share of ADRX will be exchanged for two classes of common stock - Andrx Corp-Andrx-Group and Andrx Corp-Cybear Group. As a result of the reorganization, each 100 round lot of Pharmaceutical HOLDRS will include 2 shares of Andrx Corp-Andrx Group. As a result of the reorganization, owners of one round lot of 100 PPH shares will receive 0.2978 shares of Andrx Corp-Cybear Group. Brokers have internal policies with respect to distributions of fractional shares and may distribute cash in lieu of the fractional component of the distribution.
|
||
|
September 21, 2000 |
Andrx Corporation - Cybear Group |
CYBAD |
|
|
|
The Pharmaceutical HOLDRS Trust will trade ex-distribution 0.002978 shares of Andrx Corp - Cybear Group (CYBAD) on September 21, 2000.
|
||
|
September 07, 2000 |
Andrx Corporation |
ADRX |
|
|
|
Stockholders of Andrx Corporation (ADRX) and its majority owned subsidiary Cybear Inc. (CYBA) approved a reorginization whereby Andrx will acquire the remaining outstanding shares of CYBA.
|
||
|
September 07, 2000 |
Andrx Corporation-Cybear Group Common Stock |
CYBAD |
|
|
|
Stockholders of Andrx Corporation (ADRX) and its majority owned subsidiary Cybear Inc. (CYBA) approved a reorginization whereby Andrx will acquire the remaining outstanding shares of CYBA.
|
||
|
September 07, 2000 |
Andrx Corporation-Andrx Group Common Stock |
ADRXD |
|
|
|
Stockholders of Andrx Corporation (ADRX) and its majority owned subsidiary Cybear Inc. (CYBA) approved a reorginazation whereby Andrx will acquire the remaining outstanding shares of CYBA.
|
||
|
September 01, 2000 |
King Pharmaceuticals Inc. |
KG |
|
|
|
Jones Pharma Inc. (JMED) is expected to merge with and into King Pharmaceuticals Inc. (KG). Both JMED and KG are components in the Pharmaceutical HOLDRS. Under the terms of the merger agreement, each common share of JMED will be converted into 1.125 shares of common stock of KG.
|
||
|
September 01, 2000 |
Jones Pharma Inc. |
JMED |
|
|
|
Jones Pharma Inc. (JMED) is expected to merge with and into King Pharmaceuticals Inc. (KG). Both JMED and KG are components in the Pharmaceutical HOLDRS. Under the terms of the merger agreement, each common share of JMED will be converted into 1.125 shares of common stock of KG.
|
||
|
June 20, 2000 |
Pfizer Inc. |
PFE |
|
|
|
Warner Lambert Co. (WLA) has completed its merger with and into Pfizer Inc. (PFE). Both companies are components of the IPH Index. Each outstanding share of WLA will be converted into the right to receive 2.75 shares of PFE common stock.
|
||
|
June 20, 2000 |
Warner-Lambert Co. |
WLA |
|
|
|
Warner Lambert Co. (WLA) has completed its merger with and into Pfizer Inc. (PFE). Both companies are components of the IPH Index. Each outstanding share of WLA will be converted into the right to receive 2.75 shares of PFE common stock.
|
||
|
June 20, 2000 |
Pfizer Inc. |
WLA |
2.75 |
|
|
As a result of the acquisition, 18 stocks are represented in PPH. As a result of the acquisition, each share of WLA will be converted to 2.75 shares of PFE. One round lot of 100 PPH represents 58 shares of PFE and no shares of WLA.
|
||
|
June 01, 2000 |
Pharmacia Corp. |
MTC |
5.95 |
|
|
Pharmacia Corp. (PHA) distributed from PPH after Monsanto Company (MTC) acquires Pharmacia & Upjohn, Inc. (PNU) for stock to form PHA. As a result of the acquisition, 19 stocks are represented in PPH. As a result of the acquisition, owners of one round lot of 100 PPH receive approximately 5.95 shares of PHA outside of PPH. Brokers have internal policies with respect to distributions of fractional shares and may distribute cash in lieu of the fractional component of the distribution.
|
||
|
June 01, 2000 |
Pharmacia Corp. |
PHA |
|
|
|
The Pharmaceutical HOLDRS Trust will trade ex-distribution 0.0595 shares of Pharmacia Corp. (PHA) on June 1, 2000, representing the merger consideration paid to Pharmacia & Upjohn, Inc.(PNU) shareholders when PNU merged with and into Monsanto Company (MTC).
|
||
|
May 24, 2000 |
King Pharmaceuticals Inc. |
KING |
|
|
|
|
||
|
April 03, 2000 |
Pharmacia & Upjohn |
PNU |
|
|
|
|
||
|
April 03, 2000 |
Pharmacia Corp. |
PHA |
|
|
|
Pharmacia & Upjohn, Inc. (PNU)is anticipated to merge with and into Monsanto Company (MTC). The combined entity will trade under the new name and ticker symbol Pharmacia Corp. (PHA). PNU shareholders will receive 1.19 shares of PHA.
|
||
|
March 16, 2000 |
Biovail Corporation International |
BVF |
|
|
|
|
||
